These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20119583)

  • 1. Factor structure of the neurocognitive tests: an application of the confirmative factor analysis in stabilized schizophrenia patients.
    Noh J; Kim JH; Hong KS; Kim N; Nam HJ; Lee D; Yoon SC
    J Korean Med Sci; 2010 Feb; 25(2):276-82. PubMed ID: 20119583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological profile in adult schizophrenia measured with the CMINDS.
    van Erp TG; Preda A; Turner JA; Callahan S; Calhoun VD; Bustillo JR; Lim KO; Mueller B; Brown GG; Vaidya JG; McEwen S; Belger A; Voyvodic J; Mathalon DH; Nguyen D; Ford JM; Potkin SG;
    Psychiatry Res; 2015 Dec; 230(3):826-34. PubMed ID: 26586142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
    Huguelet P; Nicastro R; Zanello A
    Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of separable cognitive factors in schizophrenia.
    Nuechterlein KH; Barch DM; Gold JM; Goldberg TE; Green MF; Heaton RK
    Schizophr Res; 2004 Dec; 72(1):29-39. PubMed ID: 15531405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of impaired processing speed on cognition in first-episode antipsychotic-naïve schizophrenic patients.
    Andersen R; Fagerlund B; Rasmussen H; Ebdrup BH; Aggernaes B; Gade A; Oranje B; Glenthoj B
    Eur Psychiatry; 2013 Aug; 28(6):332-9. PubMed ID: 22999439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Measuring the cognitive deficit associated with schizophrenia: presentation of the MATRICS neuropsychological test battery].
    Sarolta K; Pál C; István B
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):143-50. PubMed ID: 18399033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlating cognitive functions to symptom domains and insight in Egyptian patients with schizophrenia.
    Khalil AH; El-Meguid MA; Bastawy M; Rabei S; Ali R; Abd Elmoneam MHE
    Int J Soc Psychiatry; 2020 May; 66(3):240-248. PubMed ID: 31928181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia.
    Pietrzak RH; Olver J; Norman T; Piskulic D; Maruff P; Snyder PJ
    J Clin Exp Neuropsychol; 2009 Oct; 31(7):848-59. PubMed ID: 19142774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A six-factor model of cognition in schizophrenia and related psychotic disorders: relationships with clinical symptoms and functional capacity.
    Gladsjo JA; McAdams LA; Palmer BW; Moore DJ; Jeste DV; Heaton RK
    Schizophr Bull; 2004; 30(4):739-54. PubMed ID: 15957196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB).
    McCleery A; Green MF; Hellemann GS; Baade LE; Gold JM; Keefe RS; Kern RS; Mesholam-Gately RI; Seidman LJ; Subotnik KL; Ventura J; Nuechterlein KH
    Psychol Med; 2015; 45(12):2657-66. PubMed ID: 25916421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.
    Young JW; Powell SB; Risbrough V; Marston HM; Geyer MA
    Pharmacol Ther; 2009 May; 122(2):150-202. PubMed ID: 19269307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between negative symptoms and MATRICS neurocognitive domains: A meta-analysis and systematic review.
    Au-Yeung C; Penney D; Rae J; Carling H; Lassman L; Lepage M
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Dec; 127():110833. PubMed ID: 37482283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hierarchical structure of the cognitive processes in schizophrenia: the fundamental role of processing speed.
    Ojeda N; Peña J; Schretlen DJ; Sánchez P; Aretouli E; Elizagárate E; Ezcurra J; Gutiérrez M
    Schizophr Res; 2012 Mar; 135(1-3):72-8. PubMed ID: 22226902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Norwegian standardization of the MATRICS (Measurement and Treatment Research to Improve Cognition in Schizophrenia) Consensus Cognitive Battery.
    Mohn C; Sundet K; Rund BR
    J Clin Exp Neuropsychol; 2012; 34(6):667-77. PubMed ID: 22439943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystallized verbal skills in schizophrenia: relationship to neurocognition, symptoms, and functional status.
    Kurtz MM; Donato J; Rose J
    Neuropsychology; 2011 Nov; 25(6):784-791. PubMed ID: 21928906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive improvement in first-episode schizophrenia and healthy controls: A 6-year multi-assessment follow-up study.
    Fu S; Czajkowski N; Torgalsbøen AK
    Psychiatry Res; 2018 Sep; 267():319-326. PubMed ID: 29957548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cognitive deficit in schizophrenia: MATRICS Consensus Cognitive Battery].
    Rodríguez-Jiménez R; Bagney A; Moreno-Ortega M; García-Navarro C; Aparicio AI; López-Antón R; de la Oliva J; Jiménez-Arriero MÁ; Santos JL; Lobo A; Palomo T
    Rev Neurol; 2012 Nov; 55(9):549-55. PubMed ID: 23111994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of shared familial factors influencing neurocognitive endophenotypes in adult- and childhood-onset schizophrenia.
    Bigdeli TB; Nuechterlein KH; Sugar CA; Subotnik KL; Kubarych T; Neale MC; Kendler KS; Asarnow RF
    Psychol Med; 2020 Jul; 50(10):1672-1679. PubMed ID: 31362798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.